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Edited by Vladimir SkulachevAbstract The mitochondrial eﬀects of two ﬂuoride curcumin
derivatives were studied. They induced the collapse of mitochon-
drial membrane potential (Dw), increased mitochondrial respi-
ration, and decreased O2
 production and promoted Ca2þ
release. These eﬀects were reversed by the recoupling agent 6-
Ketocholestanol, but not by cyclosporin A, an inhibitor of the
permeability transition pore (PTP), suggesting that these
compounds act as uncoupling agents. This idea was reinforced
by the analysis of the physico-chemical properties of the
compounds indicating, that they are mainly in the anionic form
in the mitochondrial membrane. Moreover, they are able to
induce PTP opening by promoting the oxidation of thiol groups
and the release of cytochrome c, making these two molecules
potential candidates for induction of apoptosis.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Swelling1. Introduction
It is now widely accepted that several mitochondrial events
control the apoptosis process [1].
One of them is the mitochondrial permeability transition;
permeability transition is characterized by a sudden increase in
the permeability of the inner mitochondrial membrane to
solutes with molecular mass below 1500 Da [2]. Permeability
transition appears to be due to the opening of a pore, called the
permeability transition pore (PTP), which promotes membrane
depolarization, uncoupling of oxygen consumption and syn-
thesis of ATP, and large amplitude mitochondrial swelling.
The consequence is a loss of the outer membrane integrity,
leading to translocation of pro-apoptotic proteins from the* Corresponding author. Fax: +33-1-49-81-36-61.
E-mail address: morin@univ-paris12.fr (D. Morin).
Abbreviations: Cu12, 1,7-bis(4-hydroxy-3-ﬂuorophenyl)-1,6-heptadi-
ene-3,5-dione; Cy12, 2,6-bis(4-hydroxy-3-ﬂuorobenzylidene)cyclohex-
anone; CsA, cyclosporin A; CCCP, carbonyl cyanide
m-chlorophenylhydrazone; PTP, permeability transition pore; Dw,
mitochondrial membrane potential; 6-KCh, 6-ketocholestanol; t-BH,
tert-butylhydroperoxide
0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.05.032intermembrane space to the cytosol, with subsequent activa-
tion of caspases [3].
Thus, PTP may constitute a target to protect cells against
cellular injuries encountered during some pathologic situations
(such as ischemia-reperfusion [4]); the induction of PTP
opening may provide a strategy to induce cell death in tumor
cells [5]. This property was shown to be involved in the che-
motherapeutic eﬀect of certain anticancer drugs [6,7].
Diﬀerent reagents have been shown to induce pore opening.
They include adenine translocator reagents, oxidizing or trans-
membrane potential reducing agents such as uncouplers [8]. In a
recent work, we demonstrated that a natural yellow pigment
originally isolated from Curcuma longa L, curcumin (1,7-bis(4-
hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione), which
possesses a wide range of pharmacological properties [9], was
able to open the PTP [10]. This eﬀect was attributed to the ability
of curcumin to promote the oxidation of mitochondrial mem-
brane thiol functions; we postulated that this may be part of the
mechanism by which curcumin induces apoptosis of tumor cells
[11,12] and thus exerts its anti-proliferation activity [13].
In order to search for new antitumor agents acting on mi-
tochondria, we synthetized various analogs of curcumin, which
were compared to the well-known uncoupler agent carbonyl
cyanide m-chlorophenylhydrazone (CCCP). We present evi-
dence that two of these agents obtained by chemical substi-
tution of curcumin ([14]; Fig. 1) combine both the prooxidant
PTP inducing properties of the parent drug with potent mi-
tochondrial uncoupling properties.2. Materials and methods
Fluoride curcumin derivatives 1,7-bis(4-hydroxy-3-ﬂuorophenyl)-
1,6-heptadiene-3,5-dione (Cu12) and 2,6-bis(4-hydroxy-3-ﬂuoroben-
zylidene)cyclohexanone (Cy12) were synthetized according to the
methods described by [15]. The benzaldehyde used for synthesis of
Cu12 and Cy12 was 3-ﬂuoro-4-hydroxybenzaldehyde. The powder
obtained was puriﬁed by recrystallization. The structures of the com-
pounds were conﬁrmed by microanalysis, 1H magnetic resonance and
measurement of melting points.
Rat liver mitochondria were isolated from male Wistar rats as de-
scribed by Elimadi et al. [16]. Mitochondrial membrane potential (Dw)
was monitored by means of the ﬂuorescent dye rhodamine 123 at the
excitation and emission wavelengths of 503 and 527 nm, respectively,
[16]. Ca2þ ﬂux and mitochondrial respiration were simultaneously
measured in a thermostat-controlled reaction chamber (4 ml) at 25 C
as described previously [10]. Mitochondrial respiration was mea-
sured using a Clark-type oxygen microelectrode ﬁtted to an oxygenblished by Elsevier B.V. All rights reserved.
curcumin
Cu12
O O
OMe
OHHO
MeO
O O
F
OHHO
F
Cyclovalone
O
OH
OMeOMe
HO
Cy12
O
OH
FF
HO
Fig. 1. Chemical structures of ﬂuoride curcumin derivatives.
38 H. Ligeret et al. / FEBS Letters 569 (2004) 37–42monitoring system (Hansatech). The concentration of Ca2þ in the
extramitochondrial medium was determined by means of a speciﬁc
Ca2þ electrode (Orion) connected to the auxiliary output of the ox-
ygen monitoring system via a 720 A Orion ionometer. Swelling was
assessed by measuring the decrease in absorbance at 540 nm of a
suspension of energized or deenergized mitochondria according to [17]
and [18], respectively. The same incubation conditions were used to
study the release of cytochrome c. After incubation, the mitochondrial
suspension was centrifuged at 15 000 g for 10 min at 4 C and cy-
tochrome c levels in the supernatant were determined by western im-
munoblot analysis. The generation of O2
 was measured at 560 nm
using the reduction reaction of nitro blue tetrazolium into monofor-
mazan [19]. Brieﬂy, mitochondria (1 mg/ml) were incubated for 1 min
before the addition of 6 mM succinate which induced the production
of O2
. For this particular experiment, 1 lM cyclosporin A (CsA) was
added to the incubation medium to inhibit mitochondrial swelling
which slightly interfered with the spectroscopic detection of the re-
duction reaction. Protein thiol content was measured according to [15].
The ionization constants of solutes were measured by potentiometric
titrations using the GlpKa instrument (Sirius Analytical Instruments,
Forrest Row, UK). The pH-metric titrations were carried out in water
containing 0.15 M KCl to adjust ionic strength. Since the four com-
pounds are lipophilic, methanol was used as co-solvent. The apparent
pKa values were extrapolated to zero cosolvent using the Yasuda–
Shedlovsky procedure [20].
Titrations in the presence of diﬀerent volumes of organic solvent (n-
octanol or o-nitrophenyl octyl ether (NPOE)) were carried out. Ad-
dition of organic solvent induces a shift in the titration curve, which is
related to the pKa and the lipophilicity of the solute. The log P values
were estimated from diﬀerence Bjerrum plots and reﬁned by a non-
linear least squares procedure by including previously determined pKa
values as unreﬁned contributions. The detailed experimental proce-
dures can be found elsewhere [21,22]. All titration measurements were
carried out at 25 1 C under an argon atmosphere.3. Results
3.1. Fluoride curcumin derivatives induced mitochondrial
uncoupling
In the ﬁrst series of experiments, mitochondria (1 mg/ml)
were incubated in 1 ml of phosphate buﬀer supplemented with2 lM rotenone and 1 lMCsA, and respiration was induced by
the addition of 6 mM succinate. Cu12 and Cy12 induced a
concentration-dependent stimulation of respiration which
became obvious at about 5 lM (Fig. 2A, lines a and b).
Stimulation of respiration was associated with a concentra-
tion-dependent decrease in the membrane potential monitored
by means of rhodamine 123 (Fig. 2B). Identical results were
observed with the well-known uncoupling agent CCCP.
Parallel measurements were performed in the presence of 25
lM Ca2þ. Ca2þ was taken up and retained by mitochondria
until Cu12 or Cy12 was added (Fig. 2C). The two compounds
induced Ca2þ release; this process was insensitive to CsA, in-
dicating that it was not mediated by PTP. Similar results were
found after addition of CCCP (data not shown).
These data suggest that both Cu12 and Cy12 act as
uncouplers.
Their eﬀect on superoxide radical (O2
) generation rein-
forced this hypothesis. Fig. 2D shows that pre-incubation of
mitochondria with either 20 lM Cu12 or Cy12 totally abol-
ished O2
 production. The same result was obtained in the
presence of 1 lM CCCP.
3.2. 6-Ketocholestanol reversed mitochondrial uncoupling
induced by ﬂuoride curcumin derivatives
The same set of experiments were performed in the presence
of diﬀerent recoupling agents. Fig. 3A shows that increasing
concentrations of 6-Ketocholestanol (6-KCh) restored the
membrane potential abolished by maximal uncoupling con-
centrations of Cy12 while other recouplers, i.e., progesterone,
testosterone, atractylate or carboxyatractylate, which were
soluble in the incubation medium at the concentrations used,
were ineﬀective. Similar results were obtained with Cu12 (data
not shown). Similarly, Fig. 2A (lines c and d) and Fig. 3B show
that the increase in the respiration rate induced by Cu12, Cy12
or CCCP was inhibited by 6-KCh.3.3. Physico-chemical properties of ﬂuoride curcumin
derivatives
The physico-chemical parameters measured are reported in
Table 1. The replacement of methoxy groups by ﬂuorine atoms
induced three signiﬁcant physico-chemical changes, namely an
enhancement of the phenolic acidity, a large increase in par-
tition coeﬃcient in n-octanol/water biphasic system, and a
large increase in D log PNoct–npoe parameter. If the latter change
was associated only with the formation of an intramolecular
hydrogen bond in the neutral form of methoxy derivatives, the
higher lipophilicity and the higher acidity of ﬂuoride deriva-
tives suggested that this substitution increased the concentra-
tion of the anionic forms in organic media. However,
measurements of free energy associated with interfacial
transfer of anionic forms in order to characterize their lipo-
philicity [23] were not possible due to non-optimal conditions
for voltammetry experiments.3.4. Eﬀect of ﬂuoride curcumin derivatives on mitochondrial
swelling
Mitochondrial swelling was ﬁrst measured in energized mi-
tochondria. In a ﬁrst series of experiments, the protocol of
Bernardi et al. [17] was used. Mitochondria were loaded with
25 lM Ca2þ and then the swelling was promoted by the ad-
dition of either Cu12, Cy12 or CCCP. The three compounds
Fig. 2. Eﬀect of Cu12 and Cy12 on mitochondrial respiration, membrane potential, Ca2þ ﬂuxes and O2 production. Panel A: Liver mitochondria (1
mg/ml) were incubated in 1 ml of phosphate buﬀer containing 0.25 M sucrose and 5 mM KH2PO4 supplemented with 2 lM rotenone, pH 7.2, at 25
C. Respiration was initiated by the addition of 6 mM succinate in the presence of increasing concentrations of either Cu12 (lines a, c) or Cy12 (lines
b and d). These experiments were performed in the absence (lines a and b) or in the presence of 400 lM 6-KCh (lines c and d). Panel B: Mitochondria
(0.5 mg/ml) were added to 1.8 ml of phosphate buﬀer supplemented with 2 lM rotenone, 0.3 lM rhodamine 123 and 1 lM CsA. Dw was measured
after the addition of 6 mM succinate, followed (arrow) by increasing concentrations of Cy12 (2.5 lM, line b; 5 lM, line c; 6 lM, line d; 7.5 M, line e;
10 lM, line f; 20 lM, line h), 10 lM Cu12 (line g) or 1 lM CCCP (line i). Line a, no addition. Panel C: Mitochondria (4 mg) were added to 4 ml of
phosphate buﬀer supplemented with 2 lM rotenone, 6 mM succinate and 1 lMCsA and loaded with 25 lMCa2þ. Addition (arrow) of either 20 lM
Cu12 (line b) or 20 lM Cy12 (lines c) induced a simultaneous increase in mitochondrial respiration and Ca2þ release. A total Ca2þ release was
observed after addition of either 30 lMCu12 (line d) or 30 lMCy12 (line e). Line a, control. ‘‘r’’ values correspond to the respiration rates expressed
in nmol/min/mg protein. Panel D: Mitochondria (1 mg/ml) were incubated in 1.2 ml of phosphate buﬀer supplemented with 2 lM rotenone, 1 lM
CsA and 100 lM nitro blue tetrazolium. O2
 production was initiated by addition of 6 mM succinate (line a) and inhibited in the presence of either 1
lM CCCP (line b), 20 lM Cu12 (line c), or 20 lM Cy12 (line d). Superoxide dismutase (1000 units; line e) and a-tocopherol (300 lM; line f) were
used as reference compounds.
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c release, which was fully sensitive to CsA and therefore
mediated by the PTP (Fig. 4A). Given that, under these assay
conditions, the eﬀect of CCCP on the pore was attributed to
the depolarization of the mitochondrial membrane [24], we
hypothesized that the same mechanism of action (i.e., uncou-
pling eﬀect) could be considered for curcumin derivatives. This
assumption was reinforced by the fact that 500 lM 6-KCh
completely abolished the eﬀect of Cu12 and Cy12 (Fig. 4A).
In a second series of experiments, mitochondria were incu-
bated in phosphate buﬀer and swelling was obtained by the
addition of Ca2þ (Fig. 4B). Preincubation of mitochondria for
2 min with either CCCP, Cu12 or Cy12 inhibited mitochon-
drial swelling, conﬁrming that these drugs acted as uncouplers.
This eﬀect was concentration-dependent with IC50 values of
0.01, 5.5 and 11.5 lM, respectively (not shown). Indeed, the
elimination of the transmembrane potential by the drugs pre-
vented Ca2þ uptake and thus PTP opening (Fig. 4B).
We then measured mitochondrial swelling in de-energized
mitochondria. Under these particular experimental conditions,
respiration and membrane potential are eliminated and mito-chondrial swelling cannot be ascribed to mitochondrial un-
coupling as conﬁrmed by the fact that CCCP was unable to
induce swelling. Conversely, Cu12 and Cy12 caused mito-
chondrial swelling and this eﬀect was due to PTP opening as
attested by the inhibition eﬀect of CsA (Fig. 4C).
3.5. Fluoride curcumin derivatives promoted thiol oxidation
It is now well-established that PTP opening is related to
membrane protein thiol status [25], and we recently described
that curcumin is able to oxidize mitochondrial membrane
thiol functions [15]. Therefore, it was logical to assume that
mitochondrial membrane thiol oxidation might be the trigger
of PTP opening when it is unrelated to membrane depolar-
ization. Indeed, Table 2 demonstrates that Cu12 and Cy12
promoted membrane thiol oxidation and Fig. 4C shows that
the thiol substitution compound N-ethylmaleimide com-
pletely prevented Cu12 and Cy12-induced swelling, suggest-
ing that a thiol group is involved in swelling induction. Thus,
this eﬀect appears to be independent of the uncoupling
properties of the drugs but related to their prooxidant
properties.
Fig. 3. Eﬀect of 6-KCh on Cu12 and Cy12-induced uncoupling. Panel
A: experimental conditions were similar to Fig. 2B. The collapse of Dw
was induced by the addition of 20 lMCy12 (line a). The eﬀect of Cy12
was reversed by increasing concentrations of 6-KCh: 25 lM (line b), 50
lM (line c), 100 lM (line d), 200 lM (line e), 300 lM (line f) and 600
lM (line g). Other recouplers, i.e, atractylate (3 lM), carboxya-
tractylate (3 lM), testosterone (500 lM) and progesterone (500 lM)
were without eﬀect. Line h shows the result obtained after addition of
carboxyatractylate. Panel B: respiration rate was measured as de-
scribed in Fig. 2A. The presence of either 15 lMCu12, 15 lMCy12 or
1 lM CCCP induced a maximal increase in respiration rate (100%)
that is inhibited by 6-KCh in a concentration-dependent manner.
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The results of the present study show that incubation of rat
liver mitochondria with micromolar concentrations of the
curcumin derivatives Cu12 and Cy12 induced an increase in
the mitochondrial respiratory rate and a dose-dependant col-
lapse of Dw. These molecules also promoted the release of
Ca2þ from Ca2þ pre-loaded mitochondria but prevented Ca2þ-
induced swelling. These results suggest that Cu12 and Cy12 act
as uncoupling agents, since these events have been associated
with the eﬀects of several uncouplers, e.g., SF6847 [26], pi-
nacidil and diazoxide [27], CCCP, 2,4-dinitrophenol, and
palmitate [28].
This idea is reinforced by the observation that the two
compounds were also able to inhibit the production of O2
.Table 1
Physico-chemical parameters of curcumin and curcumin derivatives
Compound pKa1 pKa2 log
Curcumin 9.39 7.97 3.2
Cu12 7.60 6.53 5.1
Cyclovalone 9.52 8.00 3.6
Cy12 7.87 6.78 4.9
a log P of the neutral form measured by potentiometry.
b log PNoct–npoe ¼ log PNoct  log PNnpoe:Indeed, Korshunov et al. [29] have demonstrated that the rate
of H2O2 production (generated after O2
 dismutation) in rat
heart mitochondria was inhibited by a protonophorous un-
coupler. The mechanism would involve a decrease in the life-
time of the ubisemiquinone anion and some other electron
transport intermediates competent in the reduction of O2 to
O2
 [30] caused by the lowering of Dw.
The mechanism of action of uncouplers is not yet well-es-
tablished. Uncouplers translocate protons from the inter-
membrane space to the matrice when they cross the membrane
in their protonated form. This is followed by the translocation
of their deprotonated form to the outer side of the membrane
to bind another proton. The action of low concentrations of
several uncouplers can be suppressed by speciﬁc inhibitors,
suggesting that uncoupling is protein facilitated [26–28,31].
These proteins localized in the membrane seem to be necessary
for the translocation of the uncoupler [26,32].
Therefore, to investigate the mechanism of action of Cu12
and Cy12, we analyzed their physico-chemical properties and
tested the eﬀects of well-known recoupling agents. Restoration
of mitochondrial function appeared neither in the presence of
steroids hormones (probably because of the absence of bovine
serum albumin [26,31]), nor in the presence of atractylate or
carboxyatraclylate, two inhibitors of the ADP/ATP antiporter.
This last observation allowed us to exclude a possible role
of the ADP/ATP transporter in Cu12 or Cy12-mediated
uncoupling. On the other hand, the eﬀects of the two curcu-
min-derivatives were reversed in the presence of 6-KCh, the
3-keto-derivative of cholesterol. The mechanism of action of 6-
KCh is not well understood but it was suggested to incorporate
into the outer leaﬂet of the membrane and to induce a strong
asymmetrical increase in the membrane dipole potential and
therefore a deceleration of the protein-mediated movement of
the uncoupler agent in the membrane [26]. However, it should
be noted that to date this protein is unknown. 6-KCh was
shown to inhibit the action of uncouplers which cross the
membrane in the form of the anion, A as SF6847 or CCCP
but was ineﬀective in inhibiting uncoupling mediated by
compounds which cross the membrane in the form of a dimer
of anionic and protonated species HA2 as dinitrophenol [28].
These results are in accordance with our physico-chemical
data, which suggest that Cu12 and Cy12 can exist as A an-
ionic form in lipophilic media such as mitochondrial mem-
branes. Even if it was not possible to measure the lipophilicity
of anionic forms by cyclic voltammetry, the accumulation of
anions in organic phase can be seen qualitatively in partition
experiments by changes in organic phase coloration. It was
also clearly observed that the presence of Liþ in partition ex-
periments enhanced the organic phase coloration and, thus,
the concentration of anion in organic phase. These eﬀects are
markedly important for ﬂuorine derivatives at pH around pHPNoct
a log PNnpoe
a D log PNoct–npoe
b
4 3.57 )0.33
1 3.75 1.36
7 3.56 0.11
7 3.41 1.56
Fig. 4. Comparison of the eﬀect of Cu12, Cy12 and CCCP on mitochondrial swelling in energized and deenergized conditions. Panel A: Rat liver
mitochondria (0.5 mg/ml), energized with succinate (5 mM), were incubated in a medium containing 0.2 M sucrose, 10 mM Tris, pH 7.4, 1 mM
KH2PO4, 20 lM EGTA–Tris, 2 lM rotenone and 1 lg/ml oligomycin. After 1 min incubation, a pulse of 25 lM Ca2þ was added. Two min later,
swelling was induced (arrow) by either 20 lM Cu12 (line a), 20 lM Cy12 (line b) or 1 lM CCCP (line c). 1 lMCsA (line d) and 500 lM 6-KCh (line
e) inhibited the eﬀect of Cy12. Identical results were found with Cu12 but for clarity reasons the curves were not introduced in the ﬁgure. In the same
conditions, mitochondria were incubated for 20 min at room temperature. The release of cytochrome c was observed after addition of 1 lM CCCP,
20 lM Cu12 or 20 lM Cy12. Panel B: Liver mitochondria were preincubated for 3 min in the buﬀer supplemented with 6 mM succinate and 2 lM
rotenone, pH 7.2, at 25 C in the absence (line a) or in the presence of 50 lM Cy12 (line b), 50 lM Cu12 (line d), 1 lM CCCP (line c) or 1 lM CsA
(line e). Then, swelling was induced (arrow) by the addition of 25 lM Ca2þ. Panel C: Mitochondria were preincubated for 3 min in a buﬀer con-
taining 0.15 M sucrose, 5 mM Tris–HCl, 2 lM rotenone, and 1 lM antimycin A, pH 7.4, at 25 C. Swelling was induced (arrow) by either 40 lM
Cu12 (line a), 40 lM Cy12 (line b) or 1 lM CCCP (line c). The eﬀect of Cy12 was inhibited in the presence of 1 lM CsA (line d) or 50 M N-
ethylmaleimide (line e).
Table 2
Cu12 and Cy12-induced oxidation of membrane protein thiols
Conditions Thiol groups (%)
Control 100.0 1.8
t-BH 1 mM 66.1 4.1a
Cu12 20 lM 65.8 3.9a
Cy12 20 lM 74.4 3.2a
CCCP 1 mM 100.0 4.8
Control value, expressed as 100%, corresponds to 255 nmol of thiol
groups/mg proteins.
Values represent the meansS.D. of ﬁve experiments in triplicate.
a P < 0:01 compared to the control value.
H. Ligeret et al. / FEBS Letters 569 (2004) 37–42 417.0 underlining that not only high lipophilicity but also high
acidity and high complexation power may be responsible for
the increase in uncoupler eﬀects of Cu12 and Cy12.
All these results indicate that Cu12 and Cy12 act as un-
coupling agents. Moreover, like curcumin, they induce pro-
tein thiol groups oxidation. These properties confer on Cu12
and Cy12 the ability to promote mitochondrial swelling and
release of cytochrome c, events associated with induction of
apoptosis by PTP opening. It was recently shown that
treatment with uncouplers can induce apoptotic cell death in
tumor lines [33]. Therefore, Cu12 and Cy12 may represent
interesting antitumor agents, but this possibility remains to
be investigated.References
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